Start your engineering — CARs take to the TRAC – Nature.com
|
Start your engineering — CARs take to the TRAC
Nature.com T cells genetically engineered to express chimeric antigen receptors (CARs) that recognize tumour-associated antigens are promising anticancer agents. In particular, anti-CD19 CAR T cells can induce complete remission in patients with B-cell malignancies. |
|
Orbis Research Adds a New Report Global T-Cell Immunotherapy Market 2017 Forecast
Medgadget (blog) The Global T-Cell Immunotherapy market report offers a comprehensive evaluation of the Global T-Cell Immunotherapy industry. This report evaluates the Global market for “Global T-Cell Immunotherapy “. The Global T-Cell Immunotherapy market report … |
